Stomach fluid test could revolutionize gastric cancer diagnosis

NCT ID NCT07332104

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores a new way to diagnose gastric cancer by analyzing tiny particles called extracellular vesicles found in stomach fluid. Researchers will collect stomach fluid from 100 patients undergoing gastroscopy and use a special sensor to detect cancer-related changes. The goal is to see if this method can accurately identify gastric cancer, potentially offering a less invasive diagnostic option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a less invasive, more accurate way to diagnose gastric cancer early, potentially improving patient outcomes.

What could go wrong

This is an early-stage diagnostic study with only 100 participants. The new method may not prove more effective than current biopsy techniques, and results may not apply to all populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (GC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••